Vulinacimab (HLX-06) 是一种抗VEGFR-2单克隆抗体 (mAb)。Vulinacimab 可用于癌症研究。VEGFR-2 在某些肿瘤中过表达，对血管生成和内皮细胞的增殖、存活、迁移和分化至关重要。
| 生物活性 | Vulinacimab (HLX-06) is an anti-VEGFR-2monoclonal antibody (mAb). Vulinacimab can be used in the research of cancers. VEGFR-2, overexpressed in certain tumors, is critical in angiogenesis and the proliferation, survival, migration and differentiation of endothelial cells[1]. |
| IC50& Target | |
| CAS 号 | |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com